Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register
| dc.contributor.author | Macfarlane, Gary J | |
| dc.contributor.author | MacDonald, Ross I R | |
| dc.contributor.author | Pathan, Ejaz | |
| dc.contributor.author | Siebert, Stefan | |
| dc.contributor.author | Gaffney, Karl | |
| dc.contributor.author | Choy, Ernest | |
| dc.contributor.author | Packham, Jon | |
| dc.contributor.author | Martin, Kathryn R | |
| dc.contributor.author | Haywood, Kirstie | |
| dc.contributor.author | Sengupta, Raj | |
| dc.contributor.author | Atzeni, Fabiola | |
| dc.contributor.author | Jones, Gareth T | |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2018-07-24T11:05:08Z | |
| dc.date.available | 2018-07-24T11:05:08Z | |
| dc.date.issued | 2018-11-01 | |
| dc.description | Funding: This work was supported by Arthritis Research UK (grant 21378) conducted as part of the Fibromyalgia Optimal Management in Axial Spondyloarthritis study. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 218075 | |
| dc.identifier | 129927525 | |
| dc.identifier | 4c6013da-054d-406c-b02c-196c51951c5b | |
| dc.identifier | 85055598135 | |
| dc.identifier.citation | Macfarlane, G J, MacDonald, R I R, Pathan, E, Siebert, S, Gaffney, K, Choy, E, Packham, J, Martin, K R, Haywood, K, Sengupta, R, Atzeni, F & Jones, G T 2018, 'Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register', Rheumatology, vol. 57, no. 11, pp. 1982-1990. https://doi.org/10.1093/rheumatology/key206 | en |
| dc.identifier.doi | 10.1093/rheumatology/key206 | |
| dc.identifier.iss | 11 | en |
| dc.identifier.issn | 1462-0324 | |
| dc.identifier.other | RIS: urn:031119A450CAB072AAE972126922D4D4 | |
| dc.identifier.other | RIS: urn:031119A450CAB072AAE972126922D4D4 | |
| dc.identifier.other | ORCID: /0000-0003-2322-3314/work/72631710 | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/83703966 | |
| dc.identifier.other | ORCID: /0000-0003-4539-7147/work/153002098 | |
| dc.identifier.uri | http://hdl.handle.net/2164/10790 | |
| dc.identifier.vol | 57 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Rheumatology | en |
| dc.subject | axial spondyloarthritis | en |
| dc.subject | biologic therapy | en |
| dc.subject | cohort study | en |
| dc.subject | co-morbidity | en |
| dc.subject | disease activity | en |
| dc.subject | disease register | en |
| dc.subject | epidemiology | en |
| dc.subject | fibromyalgia | en |
| dc.subject | outcome | en |
| dc.subject | response | en |
| dc.subject | R Medicine | en |
| dc.subject | Arthritis Research UK (ARUK) | en |
| dc.subject | 21378 | en |
| dc.subject.lcc | R | en |
| dc.title | Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis : results from a UK national register | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Influence_of_co_morbid_fibromyalgia_on_disease_activity_measures_and_response_to_tumour_necrosis_factor_inhibitors_in_axial_spondyloarthritis_results_from_a_UK_national_register.pdf
- Size:
- 212.96 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
